Welcome to Cancer-Forums.net!   


Useful Links:

American Cancer Society
National Cancer Institute
Cancer Definition

Dilemma 3 For Green Fluorescent Protein Lab?

The latest news from Cancer Trials and Cancer Research around the world.

Dilemma 3 For Green Fluorescent Protein Lab?

Postby Jukka » Mon Sep 25, 2017 7:33 am

You have purified a protein that possibly is a cure for stomach cancer. By year 6 you will have tested the protein on monkeys and other animals (only humanely and only out of necessity) Y

(context information)

Year 6 is half gone. The Phase III results were very good and Tisha and Ramon can hardly wait for FDA approval. But the FDA calls for a public meeting, to which Matthew and other PETA members are invited. The FDA is concerned about possible long-term side effects of the drug on reproduction, since none of the information gathered in the trials has addressed that issue. This would involve doing more studies using monkeys. Come up with a compromise strategy to deal with this new issue and still get the medicinal protein to market quickly.
Posts: 48
Joined: Fri Jan 31, 2014 5:10 pm

Dilemma 3 For Green Fluorescent Protein Lab?

Postby Yuma » Mon Sep 25, 2017 7:38 am

Judging from the title of your question I would suggest that the correct option would be to tag the protein with GFP (green fluorescent protein) and observe if the studied protein appears anywhere near the reproductive system. If it does, the tagged protein would cause a green glow in that area and would indicate an increased possibility of it causing reproductive problems.

If there is no sign of the tagged protein in any reproductive organs then you could tentatively release the drug into the market with a conditional patent pending further Reproductive testing.

Edit: Non-scientific, okay! Sorry, sometimes my brain gets stuck in science mode...Let's see, you could look and see if any similar scientific studies have been done by other teams and published which would include data that could be useful, this doesn't have to be studies limited to your target protein, even studies done with proteins of similar structure can yield really good insight into what your protein can do. Or, you could use smaller animals with a faster generational turn over, and that might be less offensive to the general public, such as rats or mice. You could still ask the FDA for a conditional "patent pending" designation, which will allow you to release the drug into the market and continue into phase IV trials, while you are researching the reproductive effects.
Posts: 39
Joined: Sun Feb 02, 2014 10:06 am

Dilemma 3 For Green Fluorescent Protein Lab?

Postby Leverett » Mon Sep 25, 2017 8:00 am


Go to PCRM.ORG for alternative testing methods
Posts: 61
Joined: Sat Jan 04, 2014 9:42 pm

Return to Cancer News and Clinical Trials


  • Related topics
    Last post